| View |
|
DRP-12702-04
|
Rosuvastatin (as Calcium)
|
None
|
10 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Pharmevo (Pvt) Limited
|
Pakistan
|
CLIDP Conversion
|
17 December 2023
|
11 May 2025
|
| View |
|
DRP-12710-01
|
Prednisolone (as Sodium Phosphate)
|
Predisyr
|
15 mg / 5 mL
|
Syrup
|
Corticosteroid
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
12 November 2023
|
28 September 2027
|
| View |
|
DRP-12737-02
|
Telmisartan + Amlodipine (as besilate)
|
Telmal
|
80mg/5mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
02 November 2023
|
30 September 2027
|
| View |
|
DRP-12769-02
|
Ranitidine (as hydrochloride)
|
Raniden
|
25 mg/mL (50 mg/2 mL)
|
Solution for Injection (I.M./I.V.)
|
H2-Receptor Antagonist
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 November 2023
|
06 October 2027
|
| View |
|
DRP-12921-02
|
Co-Amoxiclav
|
Goclav-250
|
312.5 mg / 5 mL
|
Powder for Oral Suspension (Orange Flavor)
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd
|
India
|
CLIDP Conversion
|
27 November 2023
|
28 October 2027
|
| View |
|
DRP-12973-02
|
Ciprofloxacin (as lactate)
|
Ciproden
|
2 mg/mL (200 mg/100 mL)
|
Solution for IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
12 November 2023
|
11 November 2027
|
| View |
|
DRP-12977-02
|
Acetylcysteine
|
Q-Cetyl
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
07 November 2023
|
15 November 2027
|
| View |
|
DRP-130-06
|
Cefalexin (As Monohydrate)
|
Cefexil
|
100 mg / mL
|
Powder For Suspension (Oral Drops)
|
Cephalosporin (First Generation)
|
J.M. Tolmann Laboratories
|
Philippines
|
CLIDP Conversion
|
02 November 2023
|
30 May 2027
|
| View |
|
DRP-13053-01
|
Vildagliptin
|
Valipta
|
50 mg
|
Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
02 November 2023
|
23 November 2027
|
| View |
|
DRP-13059-03
|
Telmisartan + Amlodipine (as besilate)
|
Temsta
|
40 mg / 5 mg
|
Tablet
|
Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 November 2023
|
24 November 2027
|
| View |
|
DRP-13089-02
|
Telmisartan + Amlodipine (as besilate)
|
Temsta
|
80 mg / 10 mg
|
Tablet
|
Angiotensin II Receptor Blockers (ARBs) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
07 November 2023
|
28 November 2027
|
| View |
|
DRP-13142-02
|
Telmisartan + Amlodipine (as besilate)
|
Temsta
|
80 mg/ 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium Channel Blocker
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 November 2023
|
07 December 2027
|
| View |
|
DRP-13151-03
|
Hydrocortisone (as sodium succinate)
|
Hydroden
|
100 mg
|
Powder for Injection (I.M. /I.V.)
|
Corticosteroid for Systemic Use (Glucocorticoid)
|
Skymap Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
02 November 2023
|
12 December 2027
|
| View |
|
DRP-13157-01
|
Levothyroxine sodium
|
Levostrat
|
50 mcg
|
Tablet
|
Thyroid Hormone
|
Sterile-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
16 November 2023
|
12 December 2027
|
| View |
|
DRP-13518-01
|
Levetiracetam
|
Czure
|
250 mg
|
Film-Coated Tablet
|
Anticonvulsant
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 November 2023
|
03 March 2028
|
| View |
|
DRP-13519-02
|
Tamsulosin Hydrochloride
|
Tamsunav
|
400 mcg
|
Prolonged-Release Tablet
|
Alpha-adrenoreceptor Antagonist
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 November 2023
|
03 March 2028
|
| View |
|
DRP-13558-01
|
Lapatinib (as ditosylate monohydrate)
|
Herblock
|
250 mg
|
Film-Coated Tablet
|
Antineoplastic Agent
|
BDR Pharmaceuticals International Pvt. Ltd.-Oncology Unit
|
India
|
CLIDP Conversion
|
12 November 2023
|
09 March 2028
|
| View |
|
DRP-13613-01
|
Paracetamol + Orphenadrine Citrate
|
Anodyne
|
650 mg/ 50 mg
|
Tablet
|
Analgesic/ Antipyretic/ Muscle Relaxant
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
07 November 2023
|
21 March 2025
|
| View |
|
DRP-13669-01
|
Oxytocin
|
Xetocin
|
10 IU / mL
|
Solution for Injection (I.M./I.V.)
|
Posterior Pituitary Lobe Hormone
|
Indus Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
09 November 2023
|
23 March 2028
|
| View |
|
DRP-13672-03
|
Ampicillin (as sodium)
|
Eurozyllin 1000
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
02 November 2023
|
24 March 2028
|